ea0020p592 | Neuroendocrinology, Pituitary and Behaviour | ECE2009
Ambrosio Maria Rosaria
, Malaspina Alessandra
, De Paola Grazia
, Bondanelli Marta
, Zatelli Maria Chiara
, degli Uberti Ettore
Glucose metabolism alterations are frequently observed in acromegalic patients. Somatostatin analogues (SSTA) are the most widely used drugs to treat acromegaly, since they inhibit GH and IGF-1 levels, reduce pituitary mass, but can affect glucose metabolism. Aim of our study was to evaluate glucose metabolism alterations in acromegalic patients cured after surgery and in patients with active disease during treatment with SSTA. We studied 10 patients (group A, 5F, 55.66±1...